MEMBRANE FILTRATION OF PHARMACEUTICAL SOLUTIONS

被引:34
作者
MCKINNON, BT
AVIS, KE
机构
[1] UNIV TENNESSEE CTR HLTH SCI, COLL PHARM, DEPT CLIN PHARM, MEMPHIS, TN 38163 USA
[2] UNIV TENNESSEE CTR HLTH SCI, COLL PHARM, DEPT PHARMACEUT, MEMPHIS, TN 38163 USA
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1993年 / 50卷 / 09期
关键词
DRUG ADMINISTRATION; FILTERS; INJECTIONS; MANUFACTURING; STERILE PRODUCTS;
D O I
10.1093/ajhp/50.9.1921
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The principles and uses of membrane filtration in the preparation of pharmaceutical solutions are discussed. The preparation of pharmaceutical solutions often requires their passage through a thin polymeric membrane containing many tiny pores. The purpose is to remove viable and nonviable particles in order to clarify or sterilize the solution. Particles may be retained by sieving, entrapment, or electrostatic attraction. The largest pore size that will yield a sterile filtrate is 0.2 mum. Membrane filters are either hydrophobic or hydrophilic. The rate of flow through a filter is affected by the resistance of the filter, the viscosity of the solution, and pressure. Filters are commonly composed of mixed esters of cellulose, polysulfone, polyvinylidene difluoride, nylon 66, polycarbonate, or polytetrafluoroethylene. In selecting a membrane filter, a pharmacist must consider pore size, compatibility, fluid volume, particulate load, and the filter holder. Various tests are available to evaluate the integrity of filters. Filters are useful in testing end products for sterility. The use of an in-line filter during the administration of large-volume injectable solutions can prevent the introduction of particles, air, and microorganisms into the patient. Therapies in which a 0.2-mum filter may be contraindicated include lipid emulsions, low-dose infusions, low-volume infusions, drugs for which the pharmacologic properties are altered by the membrane filter, and drugs that adhere to the membrane. Pharmacists need an indepth understanding of the principles of filtration, the characteristics of filters, and their use in the filtration of pharmaceutical solutions.
引用
收藏
页码:1921 / 1936
页数:16
相关论文
共 71 条
[1]   STERILITY TESTING OF ANTIMICROBIAL-CONTAINING INJECTABLE SOLUTIONS PREPARED IN THE PHARMACY [J].
AKERS, MJ ;
WRIGHT, GE ;
CARLSON, KA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (11) :2414-2418
[2]  
[Anonymous], 1990, AM J HOSP PHARM, V47, P1033
[3]  
AVIS KE, 1982, STERILE PREPARATION
[4]   EFFECT OF SYRINGE FILTER AND IV ADMINISTRATION SET ON DELIVERY OF PROPOFOL EMULSION [J].
BAILEY, LC ;
TANG, KT ;
ROGOZINSKI, BA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (12) :2627-2630
[5]   SAFETY OF CHANGING INTRAVENOUS DELIVERY SYSTEMS AT LONGER THAN 24-HOUR INTERVALS [J].
BAND, JD ;
MAKI, DG .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (02) :173-178
[6]   BACTERIAL-ENDOTOXIN RETENTION BY IN-LINE INTRAVENOUS FILTERS [J].
BAUMGARTNER, TG ;
SCHMIDT, GL ;
THAKKER, KM ;
SITREN, HS ;
CERDA, JJ ;
MAHAFFEY, SM ;
COPELAND, EM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (03) :681-684
[7]  
Bozzetti F, 1990, Nutr Clin Pract, V5, P156, DOI 10.1177/0115426590005004156
[8]   CALCIUM-PHOSPHATE CRYSTAL OCCLUSION OF CENTRAL VENOUS CATHETERS USED FOR TOTAL PARENTERAL-NUTRITION IN INFANTS AND CHILDREN - PREVENTION AND TREATMENT [J].
BREAUX, CW ;
DUKE, D ;
GEORGESON, KE ;
MESTRE, JR .
JOURNAL OF PEDIATRIC SURGERY, 1987, 22 (09) :829-832
[9]   STERILITY TESTING OF HOME AND INPATIENT PARENTERAL-NUTRITION SOLUTIONS [J].
BRONSON, MH ;
STENNETT, DJ ;
EGGING, PK .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1988, 12 (01) :25-28
[10]   INTERACTION OF SODIUM ASCORBATE WITH STAINLESS-STEEL PARTICULATE-FILTER NEEDLES [J].
BUCK, GW ;
WOLFE, KR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (06) :1191-1191